Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001) (MODIFY I)
This study is currently recruiting participants.
Verified April 2014
by Merck Sharp & Dohme Corp.
Study NCT01241552 Information provided by Merck Sharp & Dohme Corp.
First Received on November 12, 2010. Last Updated on April 14, 2014
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Clostridium Difficile Infection
Additional conditions recognized in this trial
More general conditions related to this trial
Gram-Positive Bacterial Infections
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Physiological Effects of Drugs
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers